Building a Lifeline in Therapeutic Desperation: Successful Systematic Support for an Elderly Complex Tumor Patient
Vogreen Clinical Data CenterReleased 2024About 8 min read
Key Data Overview
26.71ng/mL
NSE Marker
Stable at plateau
Frozen for half a year
416pg/mL
BNP Heart Failure Marker
Baseline held
Good quality of life
Case Summary
A 74-year-old male with Non-Hodgkin B-cell lymphoma involving bone marrow, secondary cardiac amyloidosis and heart failure (unable to tolerate chemo/ICD). After 16 months of Vogreen systematic support, NSE and BNP stayed at a plateau, inflammation was controlled, liver/kidney function remained normal, and the patient maintained good quality of life (daily gardening). Vogreen down-regulates IL-6/TNF-α via NF-κB with high tolerance and low toxicity. For reference only, not medical advice.
Key Data & Reports
Please refer to the medical reports and data charts below for detailed examination results and imaging records.
Medical Reports & Data
Bone marrow pathology — Non-Hodgkin B-cell lymphoma involving marrowTumor marker test report July 2025Tumor marker test Jan 2026 — NSE and CA72-4Cardiac injury and heart failure markers — BNP and troponinCardiac function and enzyme panel reportSystemic biochemistry — liver/kidney function and electrolytesPatient quality-of-life follow-up recordsMedical imaging and pathology recordsTreatment course data trackingMultidisciplinary assessment report
Disclaimer: This page documents a real-world adjuvant care case of Vogreen Medicinal Housefly Larvae for academic exchange only. It does not constitute medical advice and cannot replace standard anti-tumor treatments such as surgery, radiotherapy or chemotherapy. Individual results vary. Please follow your physician's guidance.
